InvestorsHub Logo

north40000

10/24/16 6:11 PM

#94657 RE: jessellivermore #94656

DES: V certainly did well for me off-label in 3-4 days after 1st capsules. But Amarin or a partner better get going before Shire and Jennifer Aniston crank up...saw her ad just recently. I would expect AMRN to easily beat Shire in effectiveness, safety and price[Restasis did nothing, ~ $5k/year, and takes 6 months]:

http://optometrytimes.modernmedicine.com/optometrytimes/news/shire-gets-fda-nod-xiidra-lifitegrast-dry-eye

http://www.fiercepharma.com/marketing/actress-jennifer-aniston-s-eye-drop-addiction-leads-to-gig-as-shire-spokeswoman

http://www.fiercepharma.com/marketing/shire-s-eye-drug-setback-gives-allergan-s-restasis-a-temporary-reprieve

rafunrafun

10/24/16 11:24 PM

#94661 RE: jessellivermore #94656

What happened to the 1A settlement - I thought that Amarin would get 2 off label promotions per year. Did we not get any - I assume Anchor isn't one of them... no?

hypo

10/26/16 6:34 AM

#94739 RE: jessellivermore #94656

JL, On V Indications

When I started on V the DES I was experiencing in my left eye went away in less than 2 months. A very good thing...

But another inflammatory problem I had was regular bouts with Rosacea every month or so. This was treated with antibiotics by my dermatologist. Within 3 months this problem went away. Since initiating the 4 gram V regimen this problem has been eliminated.

I do not know the incidence of Rosacea in the population but it seems this is another prospective indication for Vascepa albeit less prominent than those you have listed.

Cheers